PROVIDENCE – Three Lifespan Corp. hospitals have earned national recognition for stroke and type 2 diabetes care.
Rhode Island Hospital, The Miriam Hospital and Newport Hospital have all received the American Heart Association/American Stroke Association’s Get With The Guidelines – Stroke Gold Plus Quality Achievement Award.
The facilities earned the awards by meeting standards for the diagnosis and treatment of stroke.
Additionally, Rhode Island Hospital received a Target: Stroke Honor Roll Elite Advanced Therapy designation. The award is presented to hospitals that comply with measures created to reduce the time between a stroke patient’s arrival and treatment with a clot-buster drug.
“This continuing recognition is a testament to the hard work of our staff who are part of a highly skilled, specialized team trained to provide rapid assessment and treatment for the acute stroke patient,” said Jo-Ann Sarafin, stroke program manager for Rhode Island Hospital.
The Miriam Hospital received the Target: Stroke Honor Roll Elite award, another recognition based on meeting measures between patient arrival time and treatment.
“It takes a team to be able to achieve these awards and it’s due to the efforts of everyone across the hospital – nurses, doctors, rehabilitation specialists and more,” said Karen Schaefer, stroke program manager for The Miriam and Newport hospitals.
All three hospitals also earned the Target: Type 2 Diabetes Honor Roll award for 12 consecutive months of more than 90% compliance with a specially developed diabetes cardiovascular composite score.
Elizabeth Graham is a PBN contributing writer.
Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.